S100B and its relation to cerebral oxygenation in neonates and infants undergoing surgery for congenital heart disease.
Age Factors
Astrocytes
/ metabolism
Biomarkers
/ blood
Brain
/ blood supply
Cardiac Surgical Procedures
/ adverse effects
Cardiopulmonary Bypass
/ adverse effects
Cerebrovascular Circulation
Female
Heart Defects, Congenital
/ blood
Humans
Infant
Infant, Newborn
Male
Oxygen
/ blood
Oxygen Consumption
Prospective Studies
Risk Factors
S100 Calcium Binding Protein beta Subunit
/ blood
Time Factors
Treatment Outcome
Up-Regulation
brain biomarkers
cardiopulmonary bypass
cerebral protection
near-infrared spectroscopy
Journal
Congenital heart disease
ISSN: 1747-0803
Titre abrégé: Congenit Heart Dis
Pays: United States
ID NLM: 101256510
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
16
06
2018
revised:
03
11
2018
accepted:
10
12
2018
pubmed:
4
1
2019
medline:
3
1
2020
entrez:
4
1
2019
Statut:
ppublish
Résumé
Neonates and infants undergoing surgery for congenital heart disease are at risk for developmental impairment. Hypoxic-ischemic brain injury might be one contributing factor. We aimed to investigate the perioperative release of the astrocyte protein S100B and its relation to cerebral oxygenation. Serum S100B was measured before and 0, 12, 24, and 48 hours after surgery. Cerebral oxygen saturation was derived by near-infrared spectroscopy. S100B reference values based on preoperative samples; concentrations above the 75th percentile were defined as elevated. Patients with elevated S100B at 24 or 48 hours were compared to cases with S100B in the normal range. Neonates (≤28 days) and infants (>28 and ≤365 days) were analyzed separately due to age-dependent release of S100B. Seventy-four patients underwent 94 surgical procedures (neonates, n = 38; infants, n = 56). S100B concentrations were higher in neonates before and after surgery at all time points (P ≤ .015). Highest values were noticed immediately after surgery. Postoperative S100B was elevated after 15 (40.5%) surgeries in neonates. There was no difference in pre-, intra-, or postoperative cerebral oxygenation. In infants, postoperative S100B was elevated after 23 (41.8%) procedures. Preoperative cerebral oxygen saturations tended to be lower (53 ± 12% vs 59 ± 12%, P = .069) and arterial-cerebral oxygen saturation difference was higher (35 ± 11% vs 28 ± 11%, P = .018) in infants with elevated postoperative S100B. In the early postoperative course, cerebral oxygen saturation was lower (54 ± 13% vs 63 ± 12%, P = .011) and arterial-cerebral oxygen saturation difference was wider (38 ± 11% vs 30 ± 10%, P = .008). Cerebral oxygen saturation was also lower for the entire postoperative course (62 ± 18% vs 67 ± 9%, P = .047). Postoperative S100B was elevated in about 40% of neonates and infants undergoing cardiac surgery. Infants with elevated postoperative S100B had impaired perioperative cerebral tissue oxygenation. No relation between S100B and cerebral oxygenation could be demonstrated in neonates.
Substances chimiques
Biomarkers
0
S100 Calcium Binding Protein beta Subunit
0
S100B protein, human
0
Oxygen
S88TT14065
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
427-437Informations de copyright
© 2019 Wiley Periodicals, Inc.